Ioannis Zafirakis, President and Director of Diana Shipping Inc. (NYSE:DSX), filed a Form 4 on September 15, 2026, disclosing the exercise of 1,000,000 warrants on September 10, 2026, resulting in the acquisition of 1,695,270 shares of common stock.
Richard J. Rothberg, General Counsel and Secretary of Dell Technologies Inc., filed a Form 4 with the SEC on September 15, 2026, reporting the sale of 6,000 shares of Class C Common Stock on September 11, 2026.
Paul J. Fribourg, a director at Estee Lauder Companies Inc, filed a Form 4 on September 15, 2026, disclosing the sale of 103,000 shares of Class A Common Stock between September 11 and September 14, 2026, with all shares held indirectly through Continental Grain …
Peter Trizzino, President of Global Sales at Dell Technologies Inc., filed a Form 4 on September 15, 2026, disclosing the sale of Class C Common Stock on September 11, 2026.
Shay Banon, Chief Technology Officer and Director of Elastic N.V., filed a statement of changes in beneficial ownership on September 15, 2026, reporting the sale of ordinary shares on September 14, 2026.
A Form 4 filed on September 15, 2026 reports that Louis Pastor, Chief Executive Officer and Director of Xerox Holdings Corp (NASDAQ:XRX), recorded transactions on September 11, 2026 related to the vesting of Restricted Stock Units and a subsequent tax-withholding disposition.
William Twomey, Chief Accounting Officer of Xerox Holdings Corp, filed a Form 4 on September 15, 2026, disclosing transactions in restricted stock units and common stock dated September 11, 2026, on NASDAQ:XRX.
Jacques-Edouard Gueden, Chief Revenue Officer of Xerox Holdings Corp, filed a Form 4 on September 15, 2026, disclosing the vesting of restricted stock units and a related tax-withholding disposition on September 11, 2026.
Eliecer Viamontes, an "Officer" Under SEC 16 Rules at Entergy Corp /DE/ (NYSE:ETR), filed a Form 4 on September 15, 2026, reporting option exercises and a common stock sale that occurred on September 14, 2026.
Eric Bjerkholt, Chief Financial Officer of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), filed a Form 4 on September 15, 2026, disclosing the vesting of restricted stock units and a subsequent sale of shares on September 14, 2026.